| Trial ID: | L7337 |
| Source ID: | NCT00383877
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir|DRUG: insulin NPH
|
| Outcome Measures: |
Primary: HbA1c, after 20 weeks of treatment | Secondary: FBG, after 20 weeks of treatment|Safety profile, during 20 weeks treatment|Proportion of subjects achieving HbA1c less than or equal to 7.0%, after 20 weeks of treatment|Within-subject variation of self measured blood glucose (SMBG) before breakfast during the trial at the end of the trial, before breakfast during the trial at the end of the trial
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
263
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-09
|
| Completion Date: |
2007-08
|
| Results First Posted: |
|
| Last Update Posted: |
2024-01-02
|
| Locations: |
Beijing, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00383877
|
